VEGFR

Catalog No.Inhibitor Name VEGFR1VEGFR2VEGFR3Other
A10001Sorafenib Tosylate
**
Raf-1,B-Raf,B-Raf (V599E)
A10880Sunitinib Malate
*
Kit,FLT3,PDGFRβ
A10996Cabozantinib
***
****
***
c-Met,Kit,Axl
A10080Ponatinib
****
Abl,PDGFRα,FGFR1
A10103Axitinib
****
****
****
PDGFRβ,Kit,PDGFRα
A10998Foretinib
***
****
****
Met,Tie-2,RON
A10963Vandetanib
**
*
A10137Nintedanib
**
***
***
LCK,FLT3,FGFR2
A10250Regorafenib
***
****
*
RET,Raf-1,Kit
A11518Pazopanib HCl
***
**
*
FGFR,PDGFR,c-Kit
A10185Cediranib
***
****
****
c-Kit,PDGFRβ,FGFR1
A10703PD173074
*
FGFR1,c-Src
A11411Dovitinib
***
***
***
FLT3,c-Kit,FGFR1
A10025Linifanib
****
****
*
CSF-1R,FLT3,Kit
A10967Vatalanib 2HCl
*
**
*
PDGFRβ,c-Kit,c-Fms
A10773RAF265
**
B-Raf
A10101Tivozanib
**
***
**
EphB2,PDGFRα,PDGFRβ
A10608Motesanib Diphosphate
****
****
***
Kit,RET,PDGFR
A10340Lenvatinib
**
****
***
PDGFRβ,FGFR1,PDGFRα
A10953Orantinib
*
PDGFRβ,FGFR1
A10254Brivanib
*
**
FGFR1
A10587MGCD-265
****
****
****
Met,RON,Tie-2
A10043AEE788
*
*
*
EGFR,HER2/ErbB2,c-Abl
A10352ENMD-2076
*
**
FLT3,RET,Aurora A
A10679OSI-930
***
***
CSF-1R,LCK,C-Raf
A10248CYC116
**
Aurora A,Aurora B,FLT3
A10502Ki8751
****
c-Kit,PDGFRα,FGFR2
A10903Telatinib
***
****
c-Kit,PDGFRα
A11518Pazopanib
***
**
*
FGFR,PDGFR,c-Kit
A10504KRN 633
*
*
*
PDGFRα,c-Kit,BTK
A13377SAR131675
**
A10198Dovitinib Dilactic Acid
***
***
***
FLT3,c-Kit,FGFR1
A11407Apatinib
****
RET,c-Kit,c-Src
A10154BMS-794833
**
Met
A10162Brivanib Alaninate
*
**
FGFR1
A11396Golvatinib
**
c-Met
A11954ZM 323881 HCl
****
A11955ZM 306416
*
Src,Abl
A16342BFH772
****
A11558SU5402
**
FGFR1,PDGFRβ
A12437Semaxanib
*
A11244LY2874455
***
FGFR2,FGFR1,FGFR4
A13234SKLB1002
**
A14156AZD2932
***
PDGFRβ,Flt3,c-Kit
A10893Taxifolin (Dihydroquercetin)
A11772CP-547632
***
FGFR
A12693BAW2881 (NVP-BAW2881)
*
***
*
C-Raf-1,B-RAFV599E,c-Abl
A13465SKLB610
*
PDGFR, FGFR2
A13819TG 100801
****
***
FGFR1, Fyn, Src
A13820TG 100572
****
***
FGFR1, Fyn, Src
A14387ltiratinib (DCC2701)
***
MET, TIE2, TRK
A15073E-3810
***
**
***
FGFR-1, FGFR-2
A15287ZM323881
****
A15792BMS-817378
***
c-Met

Notes:
1.Hover mouse over " * " to view the IC50 value.(A few compounds have proven potency but without published IC50 data.)
2.For more details about the compound, click on the product name of your interest.
3.The higher the number of " * " is, the more potent the inhibitor or activator is.
4."" refers to compounds which do inhibitory effects on the related isoform, but without specific value.

1 个项目

每页

设置升序顺序
  1. JI-101

    Catalog No. A13545
    Quick View
    VEGFR2/PDGFRβ/EphB4 抑制剂
    JI-101是一种具有血管内皮生长因子受体2(VEGFR2),血小板源性生长因子受体β(PDGFRβ)和ephrin B4受体B4(EphB4)的口服活性抑制剂,具有潜在的抗血管生成和抗肿瘤活性。 了解更多

1 个项目

每页

设置升序顺序
Rewards